Ian Orest Ihnatowycz

This profile gathers the share dealings of Ian Orest Ihnatowycz in Acerus Pharmaceuticals Corporation (formerly Trimel Pharmaceuticals Corporation). The record holds 3 filings, for trades running from 23 March 2016 to 13 May 2016.

The open-market record is one-sided, with 2 purchases worth €29k and not one sale. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay.

The latest filing, published on 18 May 2016, reports a transaction of €7.0M in Acerus Pharmaceuticals Corporation (formerly Trimel Pharmaceuticals Corporation). The last insider purchase was made public on 28 March 2016, 3,864 days ago. Typically, a trade is published a median of 5 days after it takes place. That lag is the time during which only the insider knows about the trade. This summary is built from SEDI disclosures alone and does not predict where the share price will go.